These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 6305493

  • 21. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [Abstract] [Full Text] [Related]

  • 22. Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine.
    Malis CD, Racusen LC, Solez K, Whelton A.
    J Lab Clin Med; 1984 May; 103(5):660-76. PubMed ID: 6425441
    [Abstract] [Full Text] [Related]

  • 23. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 24. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
    [Abstract] [Full Text] [Related]

  • 25. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
    Hidaka S, Tsuruoka M, Funakoshi T, Shimada H, Kiyozumi M, Kojima S.
    Ren Fail; 1994 Sep; 16(3):337-49. PubMed ID: 8059017
    [Abstract] [Full Text] [Related]

  • 26. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [Abstract] [Full Text] [Related]

  • 27. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M, Vannozzi M, Viale M, Pellecchia C, Civalleri D, Gogioso L.
    Anticancer Res; 1995 Jan; 15(6B):2541-7. PubMed ID: 8669820
    [Abstract] [Full Text] [Related]

  • 28. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK.
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [Abstract] [Full Text] [Related]

  • 29. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
    Lajer H, Kristensen M, Hansen HH, Nielsen S, Frøkiaer J, Ostergaard LF, Christensen S, Daugaard G, Jonassen TE.
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
    [Abstract] [Full Text] [Related]

  • 30. Potentiation of aminoglycoside nephrotoxicity by vitamin-D-induced hypercalcemia.
    Cohen R, Johnson K, Humes HD.
    Miner Electrolyte Metab; 1988 Nov; 14(2-3):121-8. PubMed ID: 3380067
    [Abstract] [Full Text] [Related]

  • 31. Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer treatment.
    Hacke M, Schmoll HJ, Alt JM, Baumann K, Stolte H.
    Clin Physiol Biochem; 1983 Nov; 1(1):17-26. PubMed ID: 6383688
    [Abstract] [Full Text] [Related]

  • 32. Cisplatin nephrotoxicity and protection by silibinin.
    Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H.
    Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
    [Abstract] [Full Text] [Related]

  • 33. Effect of gentamicin on isolated glomeruli and proximal tubules of the rabbit.
    Savin V, Karniski L, Cuppage F, Hodges G, Chonko A.
    Lab Invest; 1985 Jan; 52(1):93-102. PubMed ID: 3965802
    [Abstract] [Full Text] [Related]

  • 34. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
    Levi FA, Hrushesky WJ, Blomquist CH, Lakatua DJ, Haus E, Halberg F, Kennedy BJ.
    Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
    [Abstract] [Full Text] [Related]

  • 35. Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats.
    Camargo SM, Francescato HD, Lavrador MA, Bianchi ML.
    Biol Trace Elem Res; 2001 Dec; 83(3):251-62. PubMed ID: 11794517
    [Abstract] [Full Text] [Related]

  • 36. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats.
    Saad SY, Najjar TA, Alashari M.
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):862-7. PubMed ID: 15659050
    [Abstract] [Full Text] [Related]

  • 37. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
    Atasoyu EM, Yildiz S, Bilgi O, Cermik H, Evrenkaya R, Aktas S, Gültepe M, Kandemir EG.
    Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
    [Abstract] [Full Text] [Related]

  • 38. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 39. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
    Ormond PM, Basinger MA, Jones MM, Hande KR.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):246-51. PubMed ID: 1385629
    [Abstract] [Full Text] [Related]

  • 40. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.